Médicaments génériques : pivot de la reconstruction de l’industrie pharmaceutique
The pharma has a particular significance given the challenges it involves for public health, economics, politics and ethics. The medicines production is therefore subject to multiple and complex regulations, both national and international. While some of these regulations was designed against major...
Saved in:
Main Authors: | Philippe Abecassis, Nathalie Coutinet |
---|---|
Format: | Article |
Language: | English |
Published: |
Association Recherche & Régulation
2015-06-01
|
Series: | Revue de la Régulation |
Subjects: | |
Online Access: | https://journals.openedition.org/regulation/11143 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends in pharmaceutical marketing and branding research: a bibliometric analysis (2009–2023)
by: Thamburaj Anthuvan, et al.
Published: (2025-01-01) -
Toutes pour une, une pour toustes ? Ou : que faire du masculin à valeur générique ?
by: Daniel Elmiger
Published: (2021-12-01) -
Pervasive systemic disparities: medical-related gaslighting, trauma, and distrust among LGBTQ+ people in the United States
by: Dustin Z. Nowaskie, et al.
Published: (2025-02-01) -
Matthieu Montalban, Financiarisation, dynamiques des industries et modèles productifs : une analyse institutionnaliste du cas de l’industrie pharmaceutique
by: Matthieu Montalban
Published: (2008-01-01) -
Les genres récrits : chronique n° 7
by: Daniel Elmiger
Published: (2020-12-01)